Immediate Impact
32 standout
Citing Papers
Cystic fibrosis
2024 Standout
Interstitial Lung Disease
2024 Standout
Works of Benoît Douvry being referenced
Sustained effectiveness of elexacaftor-tezacaftor-ivacaftor in lung transplant candidates with cystic fibrosis
2022
Outcome of patients with interstitial lung disease admitted to the intensive care unit.
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Benoît Douvry | 178 | 171 | 48 | 113 | 14 | 326 | |
| Dauber Jh | 184 | 145 | 65 | 45 | 14 | 336 | |
| Annemie Vaneylen | 157 | 223 | 94 | 58 | 12 | 304 | |
| Kembu Nakamoto | 121 | 180 | 36 | 20 | 12 | 288 | |
| Masina Scavuzzo | 119 | 314 | 39 | 106 | 12 | 357 | |
| Luigina Marsano | 56 | 94 | 128 | 121 | 16 | 364 | |
| Drew Cutler | 85 | 115 | 41 | 93 | 21 | 371 | |
| Barry R. Cofer | 84 | 191 | 21 | 41 | 18 | 345 | |
| Maria Cristina Maresca | 49 | 141 | 81 | 101 | 17 | 364 | |
| Patrick R. Aguilar | 124 | 241 | 56 | 118 | 14 | 327 | |
| TE Starzl | 41 | 112 | 23 | 111 | 17 | 270 |
All Works
Loading papers...